| Page 2009 | Kisaco Research
 

Tim Luker

Director External Innovation, Global External R&D
Eli Lilly and Company

Tim Luker

Director External Innovation, Global External R&D
Eli Lilly and Company

Tim Luker

Director External Innovation, Global External R&D
Eli Lilly and Company
 

Esther Jiménez

Project Manager
Probisearch

Esther Jiménez

Project Manager
Probisearch

Esther Jiménez

Project Manager
Probisearch
 

Alexis Mosca

Physician Pediatrics
Robert-Debré Hospital

Alexis Mosca

Physician Pediatrics
Robert-Debré Hospital

Alexis Mosca

Physician Pediatrics
Robert-Debré Hospital
 

Jean de Gunzburg

CSO
Davoltera

Talk to me about… your research

Jean de Gunzburg

CSO
Davoltera

Jean de Gunzburg

CSO
Davoltera

Talk to me about… your research

I am the chief scientific officer at Da Volterra, a French biotechnology company, headquartered in Paris, France. Da Volterra is committed to the discovery and development of innovative approaches to prevent the deleterious consequences of antibiotic treatments on the intestinal microbiota, including the emer­gence and dissemination of antimicrobial resistance, as well as the occurrence of infections by opportunistic pathogens such as Clostridium difficile. Prior to that, I led an academic career as a cell biologist focusing on signal transduction and oncogenesis, ultimately leading a research laboratory at the Institut Curie in Paris.

 

Talk to me about…something people may not know about you

I was born in Canada, lived for most of my life in France, and am now based in the London. I am an avid off-piste skier, in the French and Swiss Alps. I particularly enjoy the slow hiking/skinning up the mountains which gives me time to appreciate the fabulous scenery, and to think in depth about new and arising matters, in particular in relation to my research.

 

Mike Kaleko

Sr. VP R&D
Synthetic Biologics

Mike Kaleko

Sr. VP R&D
Synthetic Biologics

Mike Kaleko

Sr. VP R&D
Synthetic Biologics
 

John Kokai-Kun

VP, Non-Clinical Affairs
Synthetic Biologics

John Kokai-Kun

VP, Non-Clinical Affairs
Synthetic Biologics

John Kokai-Kun

VP, Non-Clinical Affairs
Synthetic Biologics
 

Sacha Mann

CEO
Biosys UK

Sacha Mann

CEO
Biosys UK

Sacha Mann

CEO
Biosys UK
 

Lihi Segal

CEO
Day Two

Lihi Segal

CEO
Day Two

Lihi Segal

CEO
Day Two